Quantitative Sandwich ELISA for Measuring Secreted IL-2 and IFN-γ in Supernatants of Anti-CD3/CD28-Stimulated Human T Cells

Supernatants are collected from stimulated and unstimulated T-cell cultures at 24, 48, and 72 h time points, technical triplicate cultures per condition. Each ELISA plate includes a 7-point 2-fold serial-diluted recombinant standard curve plus a zero (blank), run in duplicate; samples run in duplicate wells. Include a high/low QC sample of known concentration on every plate. Pre-dilute samples (e.g., 1:2 to 1:20) to fall within the linear range. Plan biological n = 6-8 donors.

BSL-2 for handling supernatants from human cell cultures (treat as potentially infectious). 2 N sulfuric acid stop solution is corrosive — wear gloves and eye protection, add to wells carefully, neutralize spills. TMB is a suspected mutagen — avoid skin contact and dispose appropriately. PMA/ionomycin for positive controls are hazardous (tumor promoter/ionophore). PPE: gloves, lab coat, eye protection. Decontaminate biological waste with 10% bleach; dispose of acid waste per institutional chemical-waste rules.

Standard curve: recombinant cytokine 7-point dilution sets the quantitation reference. Blank/zero well (diluent only) defines background OD. Negative biological control: supernatant from unstimulated T cells. Positive biological control: PMA/ionomycin-stimulated supernatant (high cytokine). Inter-plate QC: a spiked sample of known concentration on each plate monitors plate-to-plate consistency. Spike-recovery (sample spiked with a known standard amount) validates the absence of matrix interference (target 80-120% recovery).

Standard curve OD spans ~0.1 (low standard) to ~2.5-3.0 (top standard) with a 4-parameter logistic fit R^2 ≥ 0.99. Unstimulated supernatants typically <20-50 pg/mL. Stimulated IL-2 often 500-5000 pg/mL at 24 h; IFN-γ frequently 1000-10,000 pg/mL by 48-72 h. Spike recovery 80-120%; duplicate well CV <15%; the lower limit of quantification is usually ~15-30 pg/mL depending on the kit.

• Capture and detection antibody pairs (matched) for human IL-2 and human IFN-γ, or pre-coated DuoSet/Quantikine ELISA kits
• Recombinant human IL-2 and IFN-γ standards (lyophilized, reconstituted per lot certificate)
• Streptavidin-HRP conjugate
• TMB (3,3',5,5'-tetramethylbenzidine) substrate solution
• Stop solution: 2 N H2SO4 (or 1 M)
• Coating buffer (PBS, pH 7.4); reagent diluent (PBS + 1% BSA); wash buffer (PBS + 0.05% Tween-20)
• High-binding 96-well polystyrene microplates
• Culture supernatants from anti-CD3/CD28-stimulated human T cells
• Sealing films; reagent reservoirs

To measure absolute concentrations of the Th1-associated cytokines IL-2 and IFN-γ secreted by human T cells into culture supernatant following anti-CD3/CD28 stimulation, using a quantitative colorimetric sandwich ELISA. Cytokine concentrations are interpolated from a 7-point recombinant standard curve, enabling functional comparison of T-cell activation across donors, doses, or treatment conditions.

1. Coat plates with capture antibody in PBS overnight at room temperature; seal.
2. Wash 3x with wash buffer (300 µL/well); block with 300 µL reagent diluent, 1 h at RT.
3. Wash 3x. Add 100 µL standards (7-point 2-fold dilution + blank) and pre-diluted samples in duplicate; incubate 2 h at RT.
4. Wash 3x. Add 100 µL biotinylated detection antibody; incubate 2 h at RT.
5. Wash 3x. Add 100 µL streptavidin-HRP (working dilution); incubate 20 min at RT in the dark.
6. Wash 3x. Add 100 µL TMB substrate; develop 20 min at RT in the dark (watch for color).
7. Add 50 µL stop solution (2 N H2SO4); tap to mix.
8. Read absorbance at 450 nm with 540/570 nm reference subtraction within 30 min.
9. Record OD values; verify the blank is low and the top standard is on-scale (not saturated).
10. Repeat for the second cytokine on a separate plate.

Independent: stimulation condition/strength and collection time point. Dependent: IL-2 and IFN-γ concentration (pg/mL). Controlled: antibody coating concentration, incubation times/temperatures, wash stringency, substrate development time, sample dilution factor, standard lot and reconstitution, plate reader wavelength/reference, and culture conditions (cell number, medium).

Anti-CD3/CD28-stimulated human T cells will secrete IL-2 and IFN-γ at concentrations significantly above unstimulated controls, with IL-2 peaking earlier (~24 h) and IFN-γ accumulating later (~48-72 h), and secreted levels increasing with stimulation strength in a dose-dependent fashion measurable within the linear range of the standard curve.

Subtract the blank (or reference wavelength) from all wells, average duplicates. Fit the standard curve with a 4-parameter logistic (4PL) regression in GraphPad Prism, SoftMax Pro, or MyAssays. Interpolate sample concentrations from the fit, multiply by the dilution factor, and exclude any sample reading above the top standard (re-run at higher dilution). Report pg/mL. Discard wells with duplicate CV >20%.

1. Flat/low standard curve: capture antibody coating failed or detection antibody degraded — verify coating overnight, use fresh reagents, confirm correct working dilutions. 2. High blank/background: insufficient washing or HRP carryover — increase washes to 4-5x and ensure complete aspiration. 3. Samples above top standard (off-scale): dilute samples further (e.g., 1:10-1:50) and re-run. 4. Poor spike recovery (matrix effect): dilute samples more to reduce matrix or use the kit's recommended diluent. 5. High duplicate CV: pipetting inconsistency or bubbles — use a calibrated multichannel, avoid bubbles, and read promptly after stopping.

Compare cytokine concentrations across conditions and time points with two-way repeated-measures ANOVA (factors: stimulation, time) with Sidak/Tukey multiple-comparison correction; log-transform concentrations if variance scales with the mean. For two-group comparisons use paired t-test or Wilcoxon. Alpha = 0.05. With n = 6-8 donors and large activation effects, power exceeds 0.9. Report mean ± SEM and individual donor values.